L
Lirong Teng
Researcher at Jilin University
Publications - 93
Citations - 1455
Lirong Teng is an academic researcher from Jilin University. The author has contributed to research in topics: Oxidative stress & Chemistry. The author has an hindex of 21, co-authored 87 publications receiving 1114 citations.
Papers
More filters
Journal ArticleDOI
Development of a novel niosomal system for oral delivery of Ginkgo biloba extract.
TL;DR: Niosomes are a promising oral system for delivery of GbE to the brain and can prolong the release of flavonoid glycosides in phosphate-buffered solution for up to 48 hours.
Journal ArticleDOI
Cabazitaxel-loaded human serum albumin nanoparticles as a therapeutic agent against prostate cancer.
Na Qu,Robert J. Lee,Yating Sun,Guangsheng Cai,Junyang Wang,Mengqiao Wang,Jiahui Lu,Qingfan Meng,Lirong Teng,Di Wang,Lesheng Teng +10 more
TL;DR: Cabazitaxel-loaded human serum albumin nanoparticles (Cbz-NPs) synthesized to overcome vehicle-related toxicity of current clinical formulation of the drug based on Tween-80 provide a promising therapeutic for prostate cancer.
Journal ArticleDOI
Clinical translation of folate receptor-targeted therapeutics.
TL;DR: Advancement into Phase III trials and the ongoing clinical development of several additional folate conjugates are likely to usher in a new era of clinical translation and validation of FR-targeted imaging and therapeutic agents.
Journal ArticleDOI
Studies on the Antidiabetic Activities of Cordyceps militaris Extract in Diet-Streptozotocin-Induced Diabetic Sprague-Dawley Rats
Yuan Dong,Tianjiao Jing,Qingfan Meng,Chungang Liu,Shuang Hu,Yihang Ma,Yan Liu,Jiahui Lu,Cheng Yingkun,Di Wang,Lirong Teng +10 more
TL;DR: Data showed that, similar to metformin, Cordyceps militaris extracts displayed a significant reduction in blood glucose levels by promoting glucose metabolism and strongly suppressed total cholesterol and triglycerides concentration in serum, which has great potential as a new source for diabetes treatment.
Journal ArticleDOI
Effects of Formulation Parameters on Encapsulation Efficiency and Release Behavior of Risperidone Poly( D , L -lactide-co-glycolide) Microsphere
TL;DR: The PLGA 75253A and 75255A show the potential as excipients for the monthly sustained release risperidone PLGA microspheres due to higher encapsulation efficiency and almost zero-order release kinetics of release profile.